Perspective Therapeutics (CATX) Gross Profit (2010 - 2023)

Perspective Therapeutics (CATX) posted Gross Profit of -$1.0 million for Q4 2023, down 236.86% sequentially from $738000.0 in Q3 2023.

Perspective Therapeutics (CATX) Gross Profit (2010 - 2023) Analysis & Trends

Perspective Therapeutics has reported Gross Profit for 14 years, with the latest figure at -$1.0 million in Q4 2023.

Quarterly Gross Profit changed N/A year-over-year to -$1.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $463000.0 (down 92.97% YoY) and the FY2024 annual result came in at $614000.0, up 32.61% from the prior year.
Gross Profit declined to -$1.0 million in Q4 2023 per CATX's latest filing, from $738000.0 in the prior quarter.
Over five years, Gross Profit peaked at $2.8 million in Q3 2022 and troughed at -$1.0 million in Q4 2023.
A 5-year average of $1.1 million and a median of $1.2 million in 2020 frame the typical range for Gross Profit.
The sharpest annual moves came in 2022 and 2023: Gross Profit soared 170.26% in 2022, then slumped 89.52% in 2023.
Over 5 years, Gross Profit stood at $1.1 million in 2019, then increased by 5.04% to $1.2 million in 2020, then climbed by 4.54% to $1.2 million in 2021, then soared by 127.95% to $2.8 million in 2022, then plunged by 136.32% to -$1.0 million in 2023.
According to Business Quant data, Gross Profit over the past three periods registered -$1.0 million, $738000.0, and $248000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn
10	Perspective Therapeutics	387.28 Mn	387.28 Mn	-

Download Data